ClinicalTrials.Veeva

Menu

Blood Flow Restriction and High-intense Resistance Training in Aging: Interactions Between Neuroplasticity and Muscle (BRAIN-M)

L

Lithuanian Sports University

Status

Completed

Conditions

Aging
Physical Disability
Muscle Degeneration
Cognitive Decline
Frailty
Sarcopenia

Treatments

Behavioral: MDRT
Behavioral: BFRT

Study type

Interventional

Funder types

Other

Identifiers

NCT05744167
LithuanianSportsU-11

Details and patient eligibility

About

BRAIN-M is a randomized controlled trial designed to examine the effects of a single bout or 12 weeks of blood-flow restriction training or high-intensity resistance training on cognitive function, brain health, muscular properties and physical performance in healthy older men 60-75 years old.

Full description

The BRAIN-M project is driven by the idea that understanding the mechanisms through which muscle and brain interact could offer new approaches to magnifying the beneficial and detrimental effects of exercise training on health at older age. Specifically, the investigators aim at identifying brain, blood, and muscle biomarkers that could serve as predictors of response to exercise training at either cognitive, brain, muscle or physical performance levels and study the associations between biomarkers in order to suggest a physiological model of brain-muscle and muscle-brain crosstalk in ageing. 60 male older adults (60-75y old) will be included in either 12 weeks of high-intense blood-flow restriction training (n = 20), muscle damaging resistance training (n = 20) or no exercise (n = 20). The control group will be asked to maintain their usual lifestyle.

Enrollment

60 patients

Sex

Male

Ages

60 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy male older adults
  • able to speak and read fluent Lithuanian
  • living in community during the study

Exclusion criteria

  • cognitive and neurological disorders (e.g. dementia, stroke, Parkinson, multiple sclerosis)
  • previous lower extremity injury
  • diabetes mellitus type I or II
  • no oncologic disease
  • no bone fractures in the previous year
  • deep vein thrombosis
  • cardiovascular disorders (e.g. congestive heart failure, angina pectoris, uncontrolled arrhythmia, history of myocardial infarction or coronary bypass grafting in the past year)
  • obesity (BMI >30kg/m²)
  • chronic fatigue, chronic headache, or chronic dizziness
  • ineligibility to MRI scanning (e.g. due to claustrofobia or metal implants)
  • The participants should not be engaged in any regular exercise programme during the previous 6 months (according to IPAQ), but able to perform 10 sit-ups
  • Any other consideration that interferes with the study aims and/or risk to the participant, at the discretion of the researcher

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 3 patient groups

Blood flow restriction training (BFRT)
Experimental group
Description:
Participants will engage in a supervised 12-week lower extremity resistance exercise program, 2 times per week. BFRT will be at an intensity of 40% of 1RM with an occlusive cuff placed at the proximal end of both lower extremities to restrict the return of blood flow. The cuff will be inflated to 50% of the limb occlusion pressure in the first week, which will be increased with 10% every week during the first 4 weeks to reach a maximum of 80% limb occlusion pressure on week 4 that will be kept for the remaining 9 weeks of the program. Each exercise will be performed for 4 sets of 12 repetitions with a 30-second rest period between sets and 3 minutes rest between exercises without occlusion.
Treatment:
Behavioral: BFRT
Muscle damaging resistance training (MDRT)
Experimental group
Description:
Participants will engage in a supervised 12-week lower extremity resistance exercise program, 2 times per week. MDRT will be at an intensity of 80% or 120% of 1RM. The first session will be at 120% 1RM and consist of eccentric-only exercises. The concentric phase of the movement will be supported completely by a coach. The eccentric phase of the movement will be accentuated by increasing the time under tension to six seconds. Each exercise will be performed for 4 sets of 4 repetitions with 2 minutes rest between sets and 3 minutes rest between exercises. The eccentric-only exercise session will be followed by 2 (after the first session) or 3 (after all other sessions) concentric-only exercise sessions at 80% of 1RM. Here, the eccentric phase of the movement will be supported completely by a coach. In the 12 week period, there will be a total of seven eccentric-only exercise sessions.
Treatment:
Behavioral: MDRT
Control group
No Intervention group
Description:
Control group will be asked to maintain their usual lifestyle.

Trial contacts and locations

1

Loading...

Central trial contact

Wouter Vints, MD; Nerijus Masiulis, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems